Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65 | Eastern North Carolina Now | Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

Coronavirus Disease 2019 (COVID-19)
    Publisher's Note: This post appears here courtesy of the The Daily Wire. The author of this post is Dillon Burroughs.

    Pfizer's COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

    The Israeli study was conducted among 109,000 patients who were 40 years old or older.

    "Among patients 65 years of age or older, the rates of hospitalization and death due to Covid-19 were significantly lower among those who received nirmatrelvir than among those who did not," the study published in the New England Journal of Medicine concluded. "No evidence of benefit was found in younger adults."

    The research affirmed the benefits of Paxlovid among certain older adults but showed little difference among middle-aged adults who received the treatment.

    The conclusion was based on the results of the study that found the rate of hospitalization due to COVID for 40-64-year olds was "15.2 cases per 100,000 person-days among treated patients and 15.8 cases per 100,000 person-days among untreated patients."

    Under an emergency use authorization order, the U.S. Food and Drug Administration authorized the use of Paxlovid to treat the coronavirus in December for adults and children 12 and older who are considered at high risk due to conditions like obesity, diabetes, and heart disease.

    The FDA's decision was based on a Pfizer study of patients who were unvaccinated or untreated for prior coronavirus infection.

    The Associated Press reported that 3.9 million prescriptions for the drug have been filled since it was authorized late last year. The treatment includes three pills taken twice daily for five days.

    Pfizer CEO Albert Bourla noted that he was personally using Paxlovid after testing positive for the coronavirus earlier this month. President Joe Biden also reportedly used Paxlovid after he tested positive for COVID.

    Biden tested negative days later but then quickly tested positive again in a "rebound" case. First Lady Jill Biden shared a similar rebound positive test on Wednesday.

    "After testing negative on Tuesday, just now, the first lady has tested positive for COVID-19 by antigen testing. This represents a 'rebound' positivity,'" the first lady's deputy communications director, Kelsey Donohue, said in a statement.

    "The first lady has experienced no reemergence of symptoms, and will remain in Delaware where she has reinitiated isolation procedures. The White House Medical Unit has conducted contact tracing and close contacts have been notified," she added.

    In addition to Paxlovid, Pfizer and BioNTech requested on Monday that the FDA grant an emergency use authorization for its COVID vaccine adapted to the BA.4/BA.5 versions of the Omicron variant.

    The new booster dose is intended for individuals 12 years of age and older and would be available to ship immediately, according to a news release from the company.

    "The agility of the mRNA platform, together with extensive clinical experience with the Pfizer-BioNTech COVID-19 Vaccine, has allowed us to develop, test and manufacture updated, high-quality vaccines that align to circulating strains with unprecedented speed," Bourla said. "Having rapidly scaled up production, we are positioned to immediately begin distribution of the bivalent Omicron BA.4/BA.5 boosters, if authorized, to help protect individuals and families as we prepare for potential fall and winter surges."
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published)
Enter Your Comment ( no code or urls allowed, text only please )




DHS Officially Shuts Down Disinformation Board After Longtime Pause Daily Wire, Guest Editorial, Editorials, Op-Ed & Politics New Watchdog Report Claiming Ex-Trump Official Lied Four Years Ago Called Election ‘Smear’


HbAD0

Latest Op-Ed & Politics

Microsoft co-founder Bill Gates, the world’s fifth-richest man, thinks that Communist China should be praised for the way it has handled poverty.
The U.S. Air Force has continued its initiative for a more inclusive, and gender-neutral military by removing all flight sticks from their planes — effective immediately.
New data from the UK shows gender clinic referrals have doubled since previous year
Supermodel Gisele Bündchen recently opened up about her husband Tom Brady coming out of retirement and returning to the NFL.
The expert codebreaking team at the NSA is working to decipher all the statements Biden made in his speech today, which the White House has promised to walk back as soon as they figure out what on earth he was saying.

HbAD1

Underdog Trump-Republican Karoline Leavitt won the GOP primary for New Hampshire’s First Congressional District on Tuesday.
Pat Harrigan, Republican nominee for Congress in North Carolina’s 14th District, was today named a “Young Gun” by the National Republican Congressional Committee.
The U.S. Coast Guard has rescued nearly two dozen people in Florida as of Thursday morning following the devastation from Hurricane Ian, with more rescues expected throughout the day.
In an ingenious move commonly used by pet owners, White House staff members have announced that they will be fitting Joe Biden with a custom-made jingle bell collar that will make it easier for them to locate the wayward President when he wanders off aimlessly.
European Commission President Ursula von der Leyen said on Wednesday that the European Union might redistribute profits from fossil fuel companies and impose energy consumption limits.
National publication The Hill lists North Carolina's U.S. Senate race among the seven contests nationwide where partisan control is most likely to "flip."

HbAD2

Utah GOP Senator Mitt Romney, who has been suspected of being squishy on conservative issues, has refused to endorse fellow Utah GOP Senator Mike Lee, a strong conservative in his re-election campaign, outraging his fellow GOP senators.

HbAD3

 
Back to Top